Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01441531
Other study ID # H-28860
Secondary ID
Status Withdrawn
Phase Phase 0
First received September 21, 2011
Last updated March 13, 2015
Start date January 2012
Est. completion date June 2014

Study information

Verified date March 2015
Source Baylor College of Medicine
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of the study is to find out if taking a dose of gabapentin 600 mg by mouth (po) before surgery will help prevent the development of tourniquet pain and hypertension while the tourniquet is inflated during orif of tibia fracture.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date June 2014
Est. primary completion date June 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria:

- Patient ages 18-64

- ASA physical status 1-3

- Schedule for orif tibia fracture with use of pneumatic tourniquet

Exclusion Criteria:

- Allergy to study medications

- polytrauma

- lower extremity crush injury

- chronic opioid use

- sickle cell disease or trait

- peripheral vascular disease

- poorly controlled hypertension

- history of DVT/PE

- morbid obesity (BMI > 35)

- patient or surgeon refusal

- patient inability to properly describe postoperative pain to investigators

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Intervention

Drug:
gabapentin 600 mg po
Given one hour before surgery
Placebo pill given one hour before surgery
Placebo pill given

Locations

Country Name City State
United States Ben Taub General Hospital Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
Baylor College of Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of tourniquet-induced hypertension Primary outcome is incidence of tourniquet-induced hypertension, which is defined as an increase of systolic or diastolic blood pressure > 30% from baseline. This will be looked at during the time of tourniquet inflation (from inflation to deflation) during the actual surgical procedure. Usual maximum inflation time is 120 minutes. During the tourniquet inflation time period Yes
Secondary Postoperative pain Postoperative pain scores for 24 hours after surgery 24 hours No
Secondary Narcotic use Total use of morphine, vicodin during 24 hours after surgery 24 hours No